Rare diseases
Investigational molecules
Locations
Back to Germany610 clinical trials in Mainz, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
GermanyStudy on the Effectiveness and Safety of Clascoterone Solution for Treating Male Pattern Hair Loss
GermanyStudy of GLPG3667 for Adults with Active Systemic Lupus Erythematosus
GermanyStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
GermanyStudy on the Long-Term Safety and Effectiveness of Minzasolmin and Iodine Ioflupane (123I) in Patients with Parkinson's Disease
GermanyStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
GermanyStudy on the Safety and Effectiveness of ESK-001 for Adults with Systemic Lupus Erythematosus
GermanyStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
GermanyStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
GermanyGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
GermanyA study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema
GermanyA Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on viral infections including studies of vaccines against respiratory syncytial virus, Herpes Zoster, and Cytomegalovirus. Research aims to evaluate vaccine efficacy and immune response in different age groups.
Special attention is given to protecting vulnerable populations, including older adults and those at increased risk.
Innovative clinical trials targeting various forms of cancer, including studies on breast cancer, pancreatic cancer, and multiple myeloma. Research focuses on novel therapeutic approaches and combination treatments.
Emphasis on personalized medicine approaches and targeted therapies for better patient outcomes.
Comprehensive studies addressing respiratory conditions, autoimmune disorders, and metabolic diseases. Research includes treatments for asthma, multiple sclerosis, and obesity.
Focus on developing long-term treatment solutions and improving quality of life for patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
